Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ACT Genomics logo — Make Personalized Medicine Accessible To All.

ACT Genomics

Make Personalized Medicine Accessible To All.

Founded 2014 Taiwan Taiwan 121 employees Series Unknown Total: $20.50M Biotechnology, Health Care +2

General Information

Company Name ACT Genomics
Founded Year 2014
Location Taiwan Taiwan +4
Founders / Decision Makers
Team member Team member
Employees 121
Industries Biotechnology, Health Care, Information Technology +1
Funding Stage Series Unknown
Social

Get notified when ACT Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ACT Genomics

ACT Genomics is a world-leading genomic test solution provider founded in 2014 and headquartered in Taiwan. The company's slogan "Make Personalized Medicine Accessible To All" reflects its commitment to providing precision medicine services globally. ACT Genomics combines tumor biology, cancer genomics, and bioinformatics expertise to offer treatment guidelines for solid tumors, relapse, drug resistance, cancer monitoring, risk assessment, and immunotherapy evaluation. The company's focus on turning every cancer patient's genetic information into actionable resolutions is supported by cutting-edge next-generation sequencing (NGS) platforms, bioinformatics analysis, and comprehensive service offerings. Their NGS platform, coupled with sophisticated bioinformatics tools and curated proprietary databases, enables them to deliver reliable results for clinical and research purposes. Moreover, their data visualization technologies make the scientific results easily understandable for everyone. In September 2020, ACT Genomics secured a Venture Round investment with participation from notable investors such as Hong Kong Science and Technology Parks Corporation, Aflac Global Ventures, and Kyoto University Innovation Capital. The company operates within the Biotechnology, Health Care, and Information Technology industries, offering clinical services including cancer prevention, early detection, treatment selection, disease monitoring, and comprehensive cancer genomic profiling and treatment options for patients with cancer. ACT Genomics also provides insights into biomarker discovery and patient stratification for clinical trials.

Taxonomy: personalized medicine, genomic testing, precision medicine, cancer genomics, bioinformatics, NGS platform, cancer monitoring, immunotherapy evaluation, clinical services, cancer prevention, early detection, treatment selection, disease monitoring, oncology, molecular information

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 3
Investor Investor
•••• •••• 		06 Sep 2020
Series C •••••• 1
Investor
26 Sep 2018
Series B •••••• 1
Investor
05 May 2016
Series A •••••• - 13 Feb 2015

ACT Genomics Alternatives & Competitors

ACT Genomics vs
Ashion Analytics
Ashion Analytics United States

We are an Exact Sciences sequencing-based Clinical laboratory. We tap into the power of the human ge...

3 employees
Biotechnology, Health Care
Compare ACT Genomics vs Ashion Analytics
ACT Genomics vs
Codex Genetics
Codex Genetics Hong Kong S.a.r.

Unraveling your uniqueness

Seed
12 employees
Biotechnology
Compare ACT Genomics vs Codex Genetics
ACT Genomics vs
Geneseeq Technology Inc.
Geneseeq Technology Inc. Canada

Cancer: a word, not a sentence!

Series D
32 employees
Biotechnology, Health Care
Compare ACT Genomics vs Geneseeq Technology Inc.

FAQ About ACT Genomics

Make Personalized Medicine Accessible To All.
ACT Genomics was founded in 2014.
ACT Genomics is headquartered in Taiwan.
ACT Genomics operates in the following industries: Biotechnology, Health Care, Information Technology, Clean Energy.
ACT Genomics has approximately 121 employees.
ACT Genomics has completed 4 funding rounds, raising a total of $20.50M. The latest funding stage is Series Unknown.
Top alternatives and competitors to ACT Genomics include Ashion Analytics, Codex Genetics, Geneseeq Technology Inc., NPG Genetik Hastalıklar Değerlendirme Merkezi, Xcoo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ACT Genomics and Ashion Analytics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ACT Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy